open access

Vol 6, No 2 (2003)
Other materials agreed with the Editors
Submitted: 2012-01-23
Published online: 2003-10-10
Get Citation

Role of myocardial perfusion imaging in risk stratification

Sobhan Vinjamuri, Radhakrishnan Jayan
Nucl. Med. Rev 2003;6(2):147-149.

open access

Vol 6, No 2 (2003)
Lecture
Submitted: 2012-01-23
Published online: 2003-10-10

Abstract

This review paper is based on a topic invited for review presented by the first author at the Annual Meeting of Society of Nuclear Medicine of Serbia and Montenegro, September 2003.
The optimal management of patients affected by coronary artery disease requires safe and cost-effective techniques for assessing the risk of subsequent cardiac events or the need for surgery. The ideal test should distinguish between high risk patients who will benefit from aggressive management and low risk patients who can be managed conservatively. Stress testing alone is believed to be inadequate for the assessment of risk. Nuclear Medicine techniques have routinely been used in the identification of patients with ischaemic heart disease and those with viable myocardium post myocardial infarction. While the essential methodology for the techniques remains same, the reporting and interpretation criteria for determining future risk are different. For instance, a fixed perfusion defect on stress myocardial perfusion imaging in a patient presenting cardiactype chest pain to the cardiologists for the first time, has a different value from a similar patient being presented to the noncardiologist for major vascular surgery.
A review of the literature concerning the current usage of nuclear cardiology techniques in risk stratification is presented.

Abstract

This review paper is based on a topic invited for review presented by the first author at the Annual Meeting of Society of Nuclear Medicine of Serbia and Montenegro, September 2003.
The optimal management of patients affected by coronary artery disease requires safe and cost-effective techniques for assessing the risk of subsequent cardiac events or the need for surgery. The ideal test should distinguish between high risk patients who will benefit from aggressive management and low risk patients who can be managed conservatively. Stress testing alone is believed to be inadequate for the assessment of risk. Nuclear Medicine techniques have routinely been used in the identification of patients with ischaemic heart disease and those with viable myocardium post myocardial infarction. While the essential methodology for the techniques remains same, the reporting and interpretation criteria for determining future risk are different. For instance, a fixed perfusion defect on stress myocardial perfusion imaging in a patient presenting cardiactype chest pain to the cardiologists for the first time, has a different value from a similar patient being presented to the noncardiologist for major vascular surgery.
A review of the literature concerning the current usage of nuclear cardiology techniques in risk stratification is presented.
Get Citation

Keywords

myocardial perfusion imaging; risk stratification

About this article
Title

Role of myocardial perfusion imaging in risk stratification

Journal

Nuclear Medicine Review

Issue

Vol 6, No 2 (2003)

Article type

Other materials agreed with the Editors

Pages

147-149

Published online

2003-10-10

Page views

551

Article views/downloads

863

Bibliographic record

Nucl. Med. Rev 2003;6(2):147-149.

Keywords

myocardial perfusion imaging
risk stratification

Authors

Sobhan Vinjamuri
Radhakrishnan Jayan

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl